CUMBERLAND PHARMACEUTICALS INC 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Griggs Jonathan
Director
Transactions
- Sale
Common Stock
2017-05-31$6.97/sh−8,000$55,760→ 10,803 total
Footnotes (1)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc.